Canadian firms to ensure safety of glucose strips
This article was originally published in Clinica
Executive Summary
Initiatives to protect the "integrity" of blood glucose strips against poor handling, shipment and documentation procedures, will be undertaken this year by members of Canada's association for medical device and technology companies (MEDEC). MEDEC's position is that "the safety and integrity of test strips is a joint responsibility of all parties in the supply chain", but research by companies has found that "further education among all parties in the supply chain - wholesalers, distributors, sales representatives, pharmacies and healthcare providers" is required to ensure that industry best practices are achieved.